These results corroborate the transcriptomic findings, indicating that downregulation of the TGF-β/PI3K/AKT and p38 MAPK pathways contributes to the protective effects of GA against D-galactose-induced inflammation and renal fibrosis. The gene discussed is TGFB1; the disease is renal fibrosis.